NCT06683105 Clinical Investigation of MYIBDDiet App Developed for Inflammatory Bowel Disease (IBD) Patients to Self-manage Their Diet
| NCT ID | NCT06683105 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Alberta |
| Condition | Inflammatory Bowel Disease (IBD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-03-15 |
| Primary Completion | 2028-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2026-03-15 with a primary completion date of 2028-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if an app designed for diet education can help patients with inflammatory bowel disease (IBD) learn about healthy eating. The main question\[s\] it aims to answer are: * Is the app easy to use? * Is the app useful? Researchers will compare the diet app to see if it is better at teaching patients about a healthy diet than the standard information they may receive from their doctor. Participants will be asked to use the app for one month and answer surveys to see how easy the app is to use and if it leads to healthier eating.
Eligibility Criteria
Inclusion Criteria: 1. ≥18 years 2. Able to provide informed consent 3. Established diagnosis of IBD determined by treating physician 4. Not in acute flare 5. Not pregnant 6. Willing and able to comply with all required study procedures Exclusion Criteria: 1. Short bowel syndrome 2. High ostomy output 3. Intestinal strictures 4. Pregnancy or breastfeeding 5. Malnutrition (evaluated by Canadian Nutrition Screening Tool (CNST) ) 6. Conditions requiring dietary restrictions (e.g. Celiac disease, kidney disease, diabetes, eosinophilic esophagitis) 7. Have other conditions that may require low fibre diet such as irritable bowel syndrome, gastroparesis. 8. Currently on a therapeutic diet 9. Already on a diet for IBD or using diet tool for IBD (e.g. Mediterranean or anti-inflammatory diet) 10. Active malignancy
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06683105 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Inflammatory Bowel Disease (IBD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06683105 currently recruiting?
Yes, NCT06683105 is actively recruiting participants. Contact the research team at kwong3@ualberta.ca for enrollment information.
Where is the NCT06683105 trial being conducted?
This trial is being conducted at Edmonton, Canada.
Who is sponsoring the NCT06683105 clinical trial?
NCT06683105 is sponsored by University of Alberta. The trial plans to enroll 40 participants.